1. Home
  2. DCTH vs UNTY Comparison

DCTH vs UNTY Comparison

Compare DCTH & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • UNTY
  • Stock Information
  • Founded
  • DCTH 1988
  • UNTY 1991
  • Country
  • DCTH United States
  • UNTY United States
  • Employees
  • DCTH N/A
  • UNTY N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • UNTY Major Banks
  • Sector
  • DCTH Health Care
  • UNTY Finance
  • Exchange
  • DCTH Nasdaq
  • UNTY Nasdaq
  • Market Cap
  • DCTH 394.9M
  • UNTY 458.0M
  • IPO Year
  • DCTH N/A
  • UNTY 1997
  • Fundamental
  • Price
  • DCTH $10.89
  • UNTY $51.75
  • Analyst Decision
  • DCTH Strong Buy
  • UNTY Buy
  • Analyst Count
  • DCTH 4
  • UNTY 3
  • Target Price
  • DCTH $24.50
  • UNTY $56.00
  • AVG Volume (30 Days)
  • DCTH 825.0K
  • UNTY 45.7K
  • Earning Date
  • DCTH 08-06-2025
  • UNTY 10-10-2025
  • Dividend Yield
  • DCTH N/A
  • UNTY 1.08%
  • EPS Growth
  • DCTH N/A
  • UNTY 30.37
  • EPS
  • DCTH 0.06
  • UNTY 4.94
  • Revenue
  • DCTH $70,240,000.00
  • UNTY $116,265,000.00
  • Revenue This Year
  • DCTH $160.46
  • UNTY $23.79
  • Revenue Next Year
  • DCTH $42.87
  • UNTY $9.20
  • P/E Ratio
  • DCTH $195.18
  • UNTY $10.52
  • Revenue Growth
  • DCTH 491.35
  • UNTY 17.14
  • 52 Week Low
  • DCTH $8.08
  • UNTY $31.44
  • 52 Week High
  • DCTH $18.23
  • UNTY $54.64
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 48.16
  • UNTY 62.05
  • Support Level
  • DCTH $10.06
  • UNTY $48.05
  • Resistance Level
  • DCTH $10.81
  • UNTY $49.40
  • Average True Range (ATR)
  • DCTH 0.71
  • UNTY 1.28
  • MACD
  • DCTH 0.13
  • UNTY 0.35
  • Stochastic Oscillator
  • DCTH 28.57
  • UNTY 86.27

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

Share on Social Networks: